Pacer Advisors Inc. Increases Holdings in Cabot Corporation $CBT

Pacer Advisors Inc. increased its position in shares of Cabot Corporation (NYSE:CBT) by 8.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 247,790 shares of the specialty chemicals company’s stock after purchasing an additional 18,538 shares during the quarter. Pacer Advisors Inc. owned 0.48% of Cabot worth $18,661,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Public Employees Retirement System of Ohio increased its holdings in Cabot by 15.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock worth $80,000 after buying an additional 160 shares during the period. Janney Montgomery Scott LLC lifted its stake in Cabot by 2.6% during the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock valued at $417,000 after acquiring an additional 161 shares during the period. Farther Finance Advisors LLC boosted its holdings in shares of Cabot by 9.6% in the 4th quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock valued at $124,000 after acquiring an additional 164 shares during the last quarter. Parallel Advisors LLC boosted its holdings in shares of Cabot by 10.5% in the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock valued at $139,000 after acquiring an additional 175 shares during the last quarter. Finally, Rothschild Investment LLC increased its stake in shares of Cabot by 170.4% in the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 259 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of NYSE CBT opened at $81.51 on Wednesday. The company has a market capitalization of $4.21 billion, a PE ratio of 15.41, a price-to-earnings-growth ratio of 11.63 and a beta of 0.84. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The company’s fifty day moving average price is $87.96 and its 200 day moving average price is $79.62. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53.

Cabot (NYSE:CBT) last released its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.37%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, research analysts predict that Cabot Corporation will post 6.37 earnings per share for the current year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. The ex-dividend date is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. Cabot’s dividend payout ratio (DPR) is 35.73%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CBT. Mizuho boosted their target price on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. UBS Group boosted their price objective on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Wall Street Zen downgraded Cabot from a “buy” rating to a “hold” rating in a research note on Saturday. JPMorgan Chase & Co. upped their target price on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Finally, Truist Financial started coverage on Cabot in a report on Monday, June 8th. They set a “buy” rating and a $98.00 target price on the stock. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $85.80.

Key Cabot News

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Adjusted EPS was $1.67, narrowly exceeding the $1.66 consensus estimate, while revenue increased 6.4% year over year to $982 million, well above expectations of $943.2 million. Cabot Tops Q3 Earnings and Revenue Estimates
• Positive Sentiment: Reinforcement Materials and Performance Chemicals generated segment EBIT of $97 million and $68 million, respectively. Cabot also reaffirmed its expectation of approximately $40 million in fiscal 2026 EBITDA from Battery Materials while expanding conductive-additive capacity in the United States and China. Cabot Corporation Reports Third Quarter Fiscal Year 2026 Results
• Neutral Sentiment: Management tightened fiscal 2026 adjusted EPS guidance to $6.15-$6.45, broadly surrounding the $6.32 analyst consensus. The earnings call provided additional discussion of operating conditions, segment performance and the company’s outlook. Cabot Q3 2026 Earnings Call Transcript
• Negative Sentiment: GAAP results were substantially weaker: net income attributable to Cabot fell to $6 million, or $0.12 per diluted share, from $101 million, or $1.86 per share, a year earlier. Adjusted EPS also declined from $1.90, reflecting a difficult comparison and $1.55 per-share impact from certain items. Cabot Reports Fiscal Q3 Net Income
• Negative Sentiment: An analyst downgraded Cabot, citing more limited upside potential and concerns extending into fiscal 2027-2028. The planned October 1 CEO transition from Sean Keohane to Erica McLaughlin adds another near-term uncertainty for investors. Cabot Successful Returns Downgrade

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.